COMPLICATIONS OF THE HOLMIUM LASER ENUCLEATION OF PROSTATE FOR BENIGN PROSTATIC HYPERPLASIA


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

Introduction. With growing experience in the HoLEP, it can replace TURP as the «gold standard» for the surgical management of BPH, and therefore this technique is the most studied surgical modality. Despite the proven effectiveness of HoLEP in the treatment of patients with BPH, its widespread use has been associated with both intra- and postoperative complications. Aim. To improve the results of surgical management of patients with BPH. Material and methods. The study comprised 310 patients who underwent HoLEP for BPH. HoLEP was performed using the Gilling’s technique. Inclusion criteria: presence of LUTS (Qmax<15 ml/s, Qav<10 ml/s, presence of residual urine, I-PSS score> 5, QoL score> 2), absence of an active inflammatory process of the urogenital organs. Results. Intraoperative complications included severe hemorrhage in 16 (5.2%), the bladder wall injury in 17 (5.5%) and the ureteral orifice injury in 2 (0.6%) patients. 275 (88.7%) had no intraoperative complications. Early postoperative complications included fever in 4 (1.3%), the bladder tamponade that required cystoscopy and evacuation of blood clots in 7 (2.3%) and acute urinary retention in 36 (11.8%) patients. 263 (84.6%) patients had no postoperative complications. Longterm postoperative complications comprised urinary incontinence in 39 (12.6%) patients and urethral strictures requiring surgical treatment in 9 (2.9%) patients. There were no long-term complications in 262 (84.5%) patients. Conclusion. HoLEP is an effective and safe surgical modality for treating patients with BPH with minimal complications, suitable for any size of the prostate.

Texto integral

Acesso é fechado

Sobre autores

D. Davydov

I.M. Sechenov First MSMU of Minzdrav of Russia (Sechenov University)

Email: ares9999@mail.ru
Urologist at the 3d Department of Urology, Urology Clinic Moscow, Russia

D. Tsarichenko

I.M. Sechenov First MSMU of Minzdrav of Russia (Sechenov University)

Email: tsarichenkodg@yandex.ru
Dr.Med.Sci., Professor at the Department of Urology Moscow, Russia

E. Bezrukov

I.M. Sechenov First MSMU of Minzdrav of Russia (Sechenov University)

Email: eabezrukov@rambler.ru
Dr.Med.Sci., Head of the 1st Department of the Urology Clinic, Prof. at the Department of Urology Moscow, Russia

R. Sukhanov

I.M. Sechenov First MSMU of Minzdrav of Russia (Sechenov University)

Email: rb_suhanov@mail.ru
Teaching Assistant at the Department of Urology Moscow, Russia

A. Vinarov

I.M. Sechenov First MSMU of Minzdrav of Russia (Sechenov University)

Email: avinarov@mail.ru
Dr.Med.Sci., Prof. at the Department of Urology Moscow, Russia

N. Sorokin

I.M. Sechenov First MSMU of Minzdrav of Russia (Sechenov University)

Email: nisorokin@mail.ru
Head of the Department of Urologic Oncology, UCH No. 2 Moscow, Russia

D. Enikeev

I.M. Sechenov First MSMU of Minzdrav of Russia (Sechenov University)

Email: enikeev_dv@mail.ru
Dr.Med.Sci., Head of the 2nd Department of the Urology Clinic, Professor at the Department of Urology Moscow, Russia

A. Dymov

I.M. Sechenov First MSMU of Minzdrav of Russia (Sechenov University)

Email: alimdv@mail.ru
Ph.D., Teaching Assistant at the Department of Urology Moscow, Russia

S. Danilov

I.M. Sechenov First MSMU of Minzdrav of Russia (Sechenov University)

Email: spdanilov@gmail.com
Teaching Assistant at the Department of Urology Moscow, Russia

Bibliografia

  1. Schulman С.С., Temml C. EAU BHP Guidelines. 2010.
  2. Lee S.H., Chung B.H., Kim C.S., Lee H.M., Kim C.I., Yoo T.K., LeeK.S., Park K.S., Byun S.S., Yoon B.I., Kim S.W., Lee J.Y. Survey on benign prostatic hyperplasia distribution and treatment patterns for men with lower urinary tract symptoms visiting urologists at general hospitals in Korea: a prospective, non-controlled, observational cohort study. Urology. 2012;79:1379-1384.
  3. Alyaev Yu.G. Diseases of the prostate gland. M.: GEOTAR-Media. (Seriya «Biblioteka vracha-spetsialista»). 2009;240 p. Russian (Аляев Ю. Г. Болезни предстательной железы. М.: ГЭОТАР-Медиа. (Серия «Библиотека врача-специалиста»). 2009;240 с.).
  4. Glybochko P.V., Alyaev Yu.G., Lokshin K.L., Dymov A.M. Holmium enucleation of the prostate in the management of patients with benign prostatic hyperplasia. Meditsinskii vestnik Bashkortostana. 2011 ;6(2):221 -24.
  5. Martov A.G., Lopatkin N.A. Manual on transurethral endoscopic electrosurgery of benign prostatic hyperplasia. M.: «Triada-Kh». 2007;144 p.
  6. Ahyai S.A., Gilling P., Kaplan S.A., Kuntz R.M., Madersbacher S., Montorsi F., Speakman M.J., Stief C.G. Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol. 2010;58:384-397.
  7. Alschibaja М., May F., Treiber U., Paul R., Hartung R. Transurethral resection for benign prostatic hyperplasia. Current developments. Urologe A. 2005;44(5):499-504.
  8. Mosoyan M.S. Complications of transurethral resection of the prostate in patients with benign prostatic hyperplasia. Ph.D. Thesis. SPb; 2004.
  9. Tsarichenko D.G. Prevention, diagnosis and treatment ofcomplications of transurethral electro-vaporization of benign prostatic hyperplasia. Ph.D. Thesis. M.: 2000.
  10. McVary K.T., Roehrborn C.G., Avins A.L., Barry M.J., Bruskewitz R.C., Donnell R.F., Foster H.E. Jr., Gonzalez C.M., Kaplan S.A., Penson D.F., Ulchaker J.C., Wei J.T. Update onAUAguideline on the management of benign prostatic hyperplasia. J Urol. 2011;185:1793-1803.
  11. Oelke M., Bachmann A., Descazeaud A., Emberton M., Gravas S., Michel M.C., N’dow J., Nordling J., de la Rosette J.J. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol. 2013;64:118-140.
  12. Gilling P.J., Cass C.B., Cresswell M.D., Fraundorfer M.R. Holmium laser resection of the prostate: preliminary results of a new method for the treatment of benign prostatic hyperplasia. Urology. 1996; 47:48-51.
  13. Gilling P.J., Cass C.B., Cresswell M.D., Malcolm A.R., Fraundorfer M.R. The use of the holmium laser in the treatment of benign prostatic hyperplasia. J Endourol. 1996;10:459-461.
  14. Elmansy H.M., Kotb A., Elhilali M.M. Holmium laser enucleation of the prostate: long-term durability of clinical outcomes and complication rates during 10 years of followup. J Urol. 2011;186:1972-1976.
  15. Dymov A.M. Laser (holmium) removal of prostate tissue in the treatment of patients with prostatic hyperplasia. Ph.D. Thesis. M., 2010.
  16. Hettiarachchi J.A., Samadi A.A., Konno S., Das A.K. Holmium laser enucleation for large (greater than 100 mL) prostate glands. Int J Urol. 2002;9:233-236.
  17. Humphreys M.R., Miller N.L., Handa S.E., Terry C., Munch L.C., Lingeman J.E. Holmium laser enucleation of the prostate - outcomes independent of prostate size? J Urol. 2008;180:2431-2435.
  18. Kim M., Lee H.E., Oh S.J. Technical Aspects of Holmium Laser Enucleation of the Prostate for Benign Prostatic Hyperplasia. Korean J Urol. 2013;54:570-579.
  19. Tyson M.D., van Rij S., Briganti.A., Gilling P., Gilling P.J. In 2013, holmium laser enucleation of the prostate (HoLEP) may be the new "gold standard". Curr Urol Rep. 2012;13:427-432.
  20. Placer J., Gelabert-Mas A., Vallmanya F., Manresa J.M., Menéndez V., Cortadellas R., Arango O. Holmium laser enucleation of prostate: outcome and complications of self-taught learning curve. Urology. 2009;73:1042-048.
  21. Montorsi F., Naspro R., Salonia A., Suardi N., Briganti A., Zanoni M. et al. Holmium laser enucleation versus transurethral resection of the prostate: results from a 2-center prospective randomized trial in patients with obstructive benign prostatic hyperplasia. J Urol. 2008;179(5 Suppl.):S87-S90

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Declaração de direitos autorais © Bionika Media, 2018